Literature DB >> 32154442

TGFβ and activin A in the tumor microenvironment in colorectal cancer.

Jasmin Zessner-Spitzenberg1,2, Alexandra L Thomas1, Nancy L Krett1, Barbara Jung1.   

Abstract

Although overall survival in colorectal cancer (CRC) is increasing steadily due to progress in screening, therapeutic options and precise diagnostic tools remain scarce. As the understanding of CRC as a complex and multifactorial condition moves forward, the tumor microenvironment has come into focus as a source of diagnostic markers and potential therapeutic targets. The role of TGFβ in shifting the epithelial cancer compartment towards invasiveness and a pro-migratory phenotype via stromal signaling has been widely investigated. Accordingly, recent studies have proposed that CRC patients could be stratified into distinct subtypes and have identified one poor prognosis subset of CRC that is characterized by high stromal activity and elevated levels of TGFβ. The TGFβ superfamily member activin A is crucial for the pro-metastatic properties of the TGFβ pathway, yet it has been under-researched in CRC carcinogenesis. In this review, we will elucidate the signaling network and interdependency of both ligands in the context of the tumor microenvironment in CRC.

Entities:  

Keywords:  TGFβ; activin A; colorectal cancer; tumor microenvironment

Year:  2019        PMID: 32154442      PMCID: PMC7061929          DOI: 10.1016/j.genrep.2019.100501

Source DB:  PubMed          Journal:  Gene Rep        ISSN: 2452-0144


  103 in total

1.  Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A.

Authors:  Lays M Sobral; Andreia Bufalino; Marcio A Lopes; Edgard Graner; Tuula Salo; Ricardo D Coletta
Journal:  Oral Oncol       Date:  2011-07-02       Impact factor: 5.337

2.  Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion.

Authors:  Prudence Donovan; Olivier A Dubey; Susanna Kallioinen; Katherine W Rogers; Katja Muehlethaler; Patrick Müller; Donata Rimoldi; Daniel B Constam
Journal:  J Invest Dermatol       Date:  2017-08-26       Impact factor: 8.551

3.  Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.

Authors:  S Zhou; P Buckhaults; L Zawel; F Bunz; G Riggins; J L Dai; S E Kern; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 4.  Targeting the Microenvironment in Advanced Colorectal Cancer.

Authors:  Daniele V F Tauriello; Eduard Batlle
Journal:  Trends Cancer       Date:  2016-08-21

5.  TGF-beta has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines.

Authors:  Nina M Muñoz; Ji Yeon Baek; William M Grady
Journal:  Growth Factors       Date:  2008-10       Impact factor: 2.511

6.  Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β.

Authors:  Yan Lan; Dong Zhang; Chunxiao Xu; Kenneth W Hance; Bo Marelli; Jin Qi; Huakui Yu; Guozhong Qin; Aroop Sircar; Vivian M Hernández; Molly H Jenkins; Rachel E Fontana; Amit Deshpande; George Locke; Helen Sabzevari; Laszlo Radvanyi; Kin-Ming Lo
Journal:  Sci Transl Med       Date:  2018-01-17       Impact factor: 17.956

7.  Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses.

Authors:  Sofia Tousa; Maria Semitekolou; Ioannis Morianos; Aggelos Banos; Aikaterini I Trochoutsou; Tess M Brodie; Nikolaos Poulos; Konstantinos Samitas; Maria Kapasa; Dimitris Konstantopoulos; Giannis Paraskevopoulos; Mina Gaga; Catherine M Hawrylowicz; Federica Sallusto; Georgina Xanthou
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

8.  Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.

Authors:  B Zhang; B Zhang; X Chen; S Bae; K Singh; M K Washington; P K Datta
Journal:  Br J Cancer       Date:  2014-01-02       Impact factor: 7.640

9.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

Review 10.  The role of TGF-β/SMAD4 signaling in cancer.

Authors:  Ming Zhao; Lopa Mishra; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2018-01-12       Impact factor: 6.580

View more
  5 in total

Review 1.  Mechanobiology of Colorectal Cancer.

Authors:  Maria Manuela Brás; Susana R Sousa; Fátima Carneiro; Manfred Radmacher; Pedro L Granja
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

2.  Role of stromal activin A in human pancreatic cancer and metastasis in mice.

Authors:  Paul Grippo; Barbara Jung; Georgina Mancinelli; Carolina Torres; Nancy Krett; Jessica Bauer; Karla Castellanos; Ron McKinney; David Dawson; Grace Guzman; Rosa Hwang; Sam Grimaldo
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

3.  TGFβ1: An Indicator for Tumor Immune Microenvironment of Colon Cancer From a Comprehensive Analysis of TCGA.

Authors:  Jinyan Wang; Jinqiu Wang; Quan Gu; Yan Yang; Yajun Ma; Quan'an Zhang
Journal:  Front Genet       Date:  2021-04-28       Impact factor: 4.599

4.  Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status.

Authors:  Bassem Refaat; Jamal Zekri; Akhmed Aslam; Jawwad Ahmad; Mohammed A Baghdadi; Abdelrazak Meliti; Shakir Idris; Sufian Sultan; Hosam Alardati; Haitham Akram Saimeh; Aiman Alsaegh; Mai Alhadrami; Tahira Hamid; Mohammed E Naeem; Shereef Ahmed Elsamany
Journal:  Pathol Oncol Res       Date:  2021-11-15       Impact factor: 3.201

Review 5.  The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches.

Authors:  Narges Zafari; Fatemeh Khosravi; Zahra Rezaee; Sahar Esfandyari; Mohamad Bahiraei; Afshin Bahramy; Gordon A Ferns; Amir Avan
Journal:  J Clin Lab Anal       Date:  2022-07-08       Impact factor: 3.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.